ha 1004 and 4-(3,4-dibutoxybenzyl)-2-imidazolidinone

ha 1004 has been researched along with 4-(3,4-dibutoxybenzyl)-2-imidazolidinone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Esuvaranathan, K; Khoo, HE; Mahendran, R; Yap, LL; Zhang, Y	1

Other Studies

1 other study(ies) available for ha 1004 and 4-(3,4-dibutoxybenzyl)-2-imidazolidinone

Article	Year
The signalling pathway for BCG-induced interleukin-6 production in human bladder cancer cells. Biochemical pharmacology, 2002, Jan-15, Volume: 63, Issue:2 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenine; Antibodies; BCG Vaccine; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Humans; Imidazoles; Interleukin-6; Isoquinolines; Phosphodiesterase Inhibitors; Protein Denaturation; RNA, Messenger; Signal Transduction; Sulfonamides; Time Factors; Tumor Cells, Cultured; Urinary Bladder Neoplasms	2002

Article

Year

The signalling pathway for BCG-induced interleukin-6 production in human bladder cancer cells.

Biochemical pharmacology, 2002, Jan-15, Volume: 63, Issue:2

Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenine; Antibodies; BCG Vaccine; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Humans; Imidazoles; Interleukin-6; Isoquinolines; Phosphodiesterase Inhibitors; Protein Denaturation; RNA, Messenger; Signal Transduction; Sulfonamides; Time Factors; Tumor Cells, Cultured; Urinary Bladder Neoplasms

2002